Virbac's Stock Soars 8.68% After Raising Annual Forecasts

Strong Opening and Positive Short-Term Dynamics

Virbac's stock price surged by 8.68% at the opening this Friday morning, reaching 338 euros, while the CAC 40 index fell by 0.8%. This increase is part of a positive short-term dynamic, with a cumulative rise of 6.29% over the last seven days. However, trading volumes remain limited, representing only 0.08% of the company's capital. Over a longer period, the performance remains mixed: the stock has seen a slight decline of 0.59% over three months and a decrease of 13.11% over one year, whereas the CAC 40 has gained 8.42% over the same period. This significant rise follows the announcement on Thursday evening of the third quarter results and the upward revision of the group's annual targets. The quarterly revenue amounted to 364.1 million euros, up 12.5% at constant exchange rates and scope, significantly exceeding market expectations which had anticipated a growth of 5.5%. For the first nine months of the year, sales reached 1.102 billion euros, driven by favorable dynamics in Europe and North America. With these results, Virbac has raised its annual growth forecast to between 5.5% and 7.5%, from a previously expected range of 4% to 6%, while maintaining its operating margin around 16%.

Technical Breakthrough and Analysts' Reactions

From a technical perspective, the stock has clearly broken through its technical resistance at 326.50 euros and is now positioned above its 50-day (323.34 euros) and 200-day (318.42 euros) moving averages, signaling a short and medium-term momentum recovery. This setup suggests an improvement in the technical trend after several months of hesitation. The Relative Strength Index (RSI), positioned at 47, remains in a neutral zone, indicating neither oversold nor overbought conditions, which potentially leaves room for further upside before reaching overheated levels. Additionally, the stock displays a contained monthly volatility of 5.67%, relatively moderate for a stock of this capitalization, while its negative beta of -0.09 indicates an almost complete lack of correlation with the movements of the CAC 40. This characteristic partly explains the strong outperformance of the day compared to the declining Paris index. Analyst reactions have followed this movement: TP ICAP Midcap has raised its price target from 400 to 407 euros with a maintained buy recommendation, while Oddo BHF keeps its buy advice with a target of 395 euros, considering that the group's new targets appear cautious given the outperformance of the first nine months.